Product description
Althea THC18
Batch 210817
Expiry: Aug 2022
Product supplied via the TGA Special Access Scheme
Althea THC18 is medicinal cannabis that can be used in the treatment of epilepsy, nausea, chronic pain and multiple sclerosis.
See a list of details to help identify the product
Reason the product is recalled
The level of tetrahydrocannabinol (THC) in this batch is too low and outside of the labelled concentration.
The hazards to consumers
If the level of tetrahydrocannabinol (THC) is too low, patients may receive a lower dose than prescribed and may find the product less effective, increasing the risk of serious health complications.
What consumers should do
Consumers who have been provided affected product will be contacted to arrange for the return and replacement of the product.
For more information, consumers should contact Althea Company Customer Care on 1300 702 020.
Details to help identify the product
Supplier running the recall
Who sold the product
Pharmacies in NSW and QLD
Dates available for sale
Where the product was sold
Responsible regulators
Regulators are established or appointed by government. They enforce regulations and rules.
Quote PRA number 2021/19324 when contacting a regulator about this recall.
Recall and remedy questions
Contact the Therapeutic Goods Administration if you have:
- a question about the remedy being offered to you by the business that is responsible for managing this recall, or
- concerns about the way the business is managing this recall.